Georgia's Online Cancer Information Center

Find A Treatment Site

Atlanta Cancer Care - Alpharetta

Atlanta Cancer Care is a medical oncology practice with ten physicians practicing at six offices located around the metropolitan Atlanta area. Atlanta Cancer Care is accredited by the American College of Radiology (ACR). The Atlanta Cancer Care practice is also a member of the Georgia CORE Research Network, a statewide network of academic and community-based oncologists and researchers. Atlanta Cancer Care provides laboratory, infusion, supportive care, and diagnostic services in all of its offices. The majority of chemotherapy treatment is provided in the Atlanta Cancer Care office, rather than the hospital. Atlanta Cancer Care participates in clinical trials which use chemotherapy drugs, and/or other drugs which affect cancer cells. Pain management, evaluation for clinical trials, behavioral health, nutrition, home health and hospice, and financial counseling services are all provided and/or coordinated by the Atlanta Cancer Care staff. Atlanta Cancer Care strives to treat the whole person and family including emotional, spiritual, nutritional, and pain management needs.

Treatment Sites in Georgia

Primary Location

3400 C Old Milton Parkway
Suite 400
Alpharetta, GA 30005
770-740-9664 (p)
770-740-9359 (f)
www.atlantacancercare.com

driving directions

Clinical Trials in Georgia

An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study
Cancer Type: Hematopoietic Malignancies, Solid Tumor

Biomarker-Driven Therapy and Immunotherapy in Screening Participants with Recurrent or Stage IV Non-Small Cell Lung Cancer (The Expanded Lung-MAP Screening Trial)
Cancer Type: Lung Cancer

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors
Cancer Type: Solid Tumor

Durvalumab vs Placebo With Stereotactic Body Radiation Therapy in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients / Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation
Cancer Type: Lung Cancer

Genetic Testing in Screening Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Cancer Type: Lung Cancer, Unknown Primary

National Cancer Institute “Cancer Moonshot Biobank”
Cancer Type: Leukemia, Lung Cancer, Multiple Myeloma, Plasma cell neoplasm, Prostate Cancer , Solid Tumor

Observation or Radiation Therapy in Treating Patients with Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Cancer Type: Brain & Spinal Cord Tumor

Testing the Addition of a Blood Pressure Medication, Carvedilol, to HER-2 Targeted Therapy for Metastatic Breast Cancer to Prevent Cardiac Toxicity
Cancer Type: Breast Cancer

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial
Cancer Type: Lung Cancer

Testing the Addition of Chemotherapy to the Usual Treatment of Ovarian Function Suppression plus Hormonal Therapy in Premenopausal ER-Positive/HER2-Negative Breast Cancer Patients Who Are At High Risk of Cancer Returning, OFSET Trial
Cancer Type: Breast Cancer, Unknown Primary

Tissue Collection and Natural History Study of Patients with Myelodysplastic Syndrome or Myeloproliferative Neoplasms
Cancer Type: Cancer-Related Syndrome, Leukemia, Myelodysplastic Syndromes (MDS)
**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.